ClinicalTrials.Veeva
Menu

Find clinical trials for Endometrial Cancer in Seattle, WA

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Cancer
Carcinoma
Breast Cancer
Ovarian Cancer
Triple Negative Breast Cancer
Ovarian Epithelial Carcinoma
Colorectal Cancer

Endometrial Cancer trials near Seattle, WA, USA:

Trial of Nab-Sirolimus in Combination With Letrozole in Patients With Advanced or Recurrent Endometrioid Endometrial Cancer

A Phase 2 Multi-center Open-label Trial of nab-Sirolimus in Combination with Letrozole in Advanced or Recurrent Endometrioid Endometrial Cancer...

Enrolling
Endometrial Cancer
Endometrioid Endometrial Cancer
Drug: nab-sirolimus

Phase 2

Aadi Bioscience

Seattle, Washington, United States and 8 other locations

(paclitaxel + carboplatin) followed by maintenance durvalumab with or without olaparib for patients with newly diagnosed advanced or recurrent endometrial...

Active, not recruiting
Endometrial Neoplasms
Drug: Carboplatin
Biological: durvalumab

Phase 3

AstraZeneca
AstraZeneca

Seattle, Washington, United States and 202 other locations

DESTINY-Endometrial01 will investigate the efficacy of first-line T-DXd + rilvegostomig (Arm A) and/or T-DXd+ pembrolizumab (Arm B) when com...

Enrolling
Endometrial Cancer
Drug: Carboplatin
Drug: Paclitaxel

Phase 3

AstraZeneca
AstraZeneca

Seattle, Washington, United States and 237 other locations

The goal of this clinical study is to find out how the study drug, sacituzumab govitecan (SG) works in participants with endometrial cancer...

Enrolling
Endometrial Cancer
Drug: Paclitaxel
Drug: Sacituzumab govitecan-hziy

Phase 3

Gilead Sciences
Gilead Sciences

Seattle, Washington, United States and 170 other locations

participants with recurrent or primary advanced (Stage III or IV) endometrial cancer....

Active, not recruiting
Neoplasms
Drug: Paclitaxel
Drug: Carboplatin

Phase 3

Tesaro
Tesaro

Seattle, Washington, United States and 168 other locations

to evaluate the efficacy and safety of ACR-368 as monotherapy or with ultra-low dose gemcitabine (ULDG) sensitization in participants with endometrial...

Enrolling
Endometrial Adenocarcinoma
Drug: ACR-368
Drug: Gemcitabine

Phase 2

Acrivon Therapeutics

Seattle, Washington, United States and 68 other locations

drug LY3484356 alone or in combination with other anticancer therapies is safe and effective in participants with advanced or metastatic breast cancer...

Active, not recruiting
Endometrial Cancer
Breast Cancer
Drug: Trastuzumab
Drug: Everolimus

Phase 1

Lilly
Lilly

Seattle, Washington, United States and 73 other locations

This study will test the safety, including side effects, and determine the characteristics of a drug called Rina-S in participants with solid tumors...

Enrolling
Uterine Cancer
Hormone Receptor-positive/Her2 Negative Breast Cancer
Drug: Carboplatin
Drug: Pembrolizumab

Phase 1, Phase 2

Genmab
Genmab

Seattle, Washington, United States and 37 other locations

This is a proof-of-concept study designed to investigate HER3-DXd monotherapy in locally advanced unresectable or metastatic solid tumors. T ...

Enrolling
Breast Cancer
Esophageal Cancer
Drug: HER3-DXd

Phase 2

Daiichi Sankyo
Daiichi Sankyo

Seattle, Washington, United States and 74 other locations

The purpose of this study is to characterize the safety, tolerability, and efficacy of IDE161 as a single agent and in combination with pembrolizumab.

Enrolling
Endometrial Cancer
Breast Cancer
Drug: Pembrolizumab
Drug: IDE-161

Phase 1

Ideaya Biosciences

Seattle, Washington, United States and 26 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems